Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer
    10.
    发明授权
    Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer 有权
    抗LFL2抗体用于诊断,预后和治疗癌症

    公开(公告)号:US07399469B2

    公开(公告)日:2008-07-15

    申请号:US11089872

    申请日:2005-03-25

    IPC分类号: A61K39/395

    摘要: Particular anti-LFL2 antibody compositions are provided herein. These antibodies may be used for diagnosis, prognosis, therapeutic monitoring and treatment of cancer, especially breast cancer, head/neck cancer, lung cancer, ovarian cancer, stomach cancer and pancreatic cancer. Furthermore, anti-LFL2 antibodies are provided herein which target the LFL2 stump remaining after proteolytic cleavage of the extracellular domain of LFL2. Additionally, anti-LFL2 antibodies are provided herein which target the stroma surrounding cancer tumors, wherein said stroma-targeting anti-LFL2 antibodies disrupt the integrity of the stroma surrounding the cancer tumor, and also make the stroma more permeable to chemotherapeutic agents and other molecular drug agents that target tumor cells.

    摘要翻译: 本文提供了特异的抗LFL2抗体组合物。 这些抗体可用于癌症,特别是乳腺癌,头颈癌,肺癌,卵巢癌,胃癌和胰腺癌的诊断,预后,治疗监测和治疗。 此外,本文提供抗LFL2抗体,其靶向LFL2细胞外结构域的蛋白水解切割后残留的LFL2残基。 另外,本文提供抗LFL2抗体,其靶向周围癌肿瘤的基质,其中所述基质靶向抗LFL2抗体破坏癌肿瘤周围基质的完整性,并且还使得基质对化学治疗剂和其它分子 靶向肿瘤细胞的药物。